Non-seminomatous germ cell tumor (NSGCT) is the second most common group of malignant testicular tumors, comprising embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed germ cell tumors. It typically occurs in young men aged 20-35 years and exhibits more aggressive biological behavior than seminoma. On ultrasonography, it is characterized by a mixed pattern with heterogeneous echotexture, cystic areas, calcifications, and foci of necrosis. Elevated AFP and/or beta-HCG provide diagnostic clues. Unlike seminoma, it is resistant to radiation therapy, and primary treatment is chemotherapy.
Age Range
20-40
Peak Age
30
Gender
Male predominant
Prevalence
Common
Non-seminomatous germ cell tumors originate from the same precursor lesion (GCNIS/IGCN) as seminoma but follow different differentiation pathways. Totipotent germ cells may undergo embryonal (embryonal carcinoma), extra-embryonal (yolk sac tumor, choriocarcinoma), or somatic (teratoma) differentiation. Mixed germ cell tumors contain multiple histological components, with the most common combination being embryonal carcinoma + teratoma. The heterogeneous appearance on ultrasonography reflects the tumor's multiple histological components — solid areas correspond to cellular components, cystic areas to teratomatous or necrotic regions, and calcifications to mature teratoma elements or dystrophic calcification. The tumor's aggressive biological behavior leads to early hematogenous and lymphatic spread.
A heterogeneous intratesticular mass containing cystic areas, solid components, and calcifications simultaneously on ultrasonography is highly typical for non-seminomatous germ cell tumor. This mixed pattern reflects the tumor's multiple histological components and is distinctly different from the homogeneous hypoechoic appearance of seminoma.
Non-seminomatous GCT appears as an intratesticular mass with heterogeneous echotexture on ultrasonography. The mass may contain solid areas of varying echogenicity, anechoic or hypoechoic cystic areas, echogenic calcifications, and areas of necrosis/hemorrhage simultaneously. Margins may be irregular and may show invasion into surrounding testicular parenchyma. This heterogeneous pattern is distinctly different from the homogeneous appearance of seminoma and is the most important finding in differential diagnosis.
Report Sentence
A mass with heterogeneous echotexture is seen within the testicular parenchyma containing cystic areas, solid components, and calcifications; non-seminomatous germ cell tumor should be primarily considered.
Color Doppler ultrasonography demonstrates hypervascularity with irregular vascular pattern in non-seminomatous GCT. Unlike the organized vascular architecture of seminoma, NSGCT shows chaotic distribution of vascular structures. Avascular zones in necrotic areas coexist with dense vascularity in solid components. Spectral Doppler may reveal high flow velocities and low resistive index. Vascularity is particularly prominent when choriocarcinoma component is present.
Report Sentence
Color Doppler examination demonstrates hypervascularity with irregular vascular pattern, with coexisting avascular necrotic areas and vascular solid areas.
Calcifications are an important finding in non-seminomatous GCT. Coarse calcifications may indicate mature teratoma component, while fine punctate calcifications may indicate dystrophic calcification or psammoma bodies. Cystic components may be due to teratomatous elements, necrosis, or yolk sac tumor component. This combination is rarely seen in seminoma and is a strong clue favoring non-seminomatous tumor.
Report Sentence
Coarse calcifications and cystic components are seen within the mass, consistent with non-seminomatous germ cell tumor with teratomatous component.
On T2-weighted MRI sequences, NSGCT demonstrates heterogeneous signal intensity. Solid components show low-to-intermediate signal, cystic areas high signal, and hemorrhagic areas variable signal. In mature teratoma component, fat content shows intermediate-to-high signal on T2, while cartilage shows low signal. This complex signal pattern reflects the tumor's multiple histological composition and is distinctly different from the homogeneous low T2 signal of seminoma.
Report Sentence
The testicular mass demonstrates heterogeneous signal intensity on T2-weighted sequences with mixed cystic and solid components.
On T1-weighted sequences, NSGCT shows heterogeneous signal. Solid components appear isointense to slightly hypointense, cystic areas hypointense. Hemorrhagic areas appear T1 hyperintense in the subacute phase (methemoglobin), reflecting the tumor's aggressive nature. Hemorrhage is particularly prominent when choriocarcinoma component is present. Fat tissue in mature teratoma component shows hyperintense signal on T1 with signal loss on fat-suppressed sequences.
Report Sentence
The mass shows heterogeneous signal on T1-weighted sequences with focal hyperintense areas consistent with hemorrhage.
On DWI, NSGCT demonstrates heterogeneous diffusion restriction. Highly cellular solid components (especially embryonal carcinoma) show marked diffusion restriction, while cystic areas and mature teratoma components do not show restriction. On the ADC map, heterogeneous low ADC values are seen in solid areas and high ADC values in cystic areas. This heterogeneous diffusion pattern differs from the homogeneous restriction of seminoma.
Report Sentence
The mass demonstrates heterogeneous diffusion restriction on DWI with marked restriction in solid components and no restriction in cystic areas.
On contrast-enhanced CT, NSGCT demonstrates heterogeneous enhancement. Solid components enhance variably, while necrotic and cystic areas do not enhance. Calcifications are identified as high-density foci. CT is primarily used for staging — retroperitoneal lymphadenopathy, pulmonary metastases, and hepatic metastases are evaluated. Unlike seminoma, NSGCT may show early hematogenous spread to the lungs.
Report Sentence
The testicular mass demonstrates heterogeneous enhancement on contrast-enhanced CT with non-enhancing necrotic areas and calcific foci.
CT plays a critical role in evaluating retroperitoneal and mediastinal lymphadenopathy and pulmonary metastases in NSGCT staging. Unlike seminoma, NSGCT may show early hematogenous spread, and pulmonary metastases may be detected at diagnosis. Retroperitoneal masses in NSGCT may appear heterogeneous, containing necrotic areas and cystic components. Pulmonary metastases are typically seen as multiple, round, peripheral nodules.
Report Sentence
Staging CT should evaluate for retroperitoneal lymphadenopathy and pulmonary metastases; early hematogenous spread risk exists in NSGCT.
Criteria
Comprises 40-60% of all testicular GCTs. Combination of two or more histological components. Most common combination: embryonal carcinoma + teratoma (teratocarcinoma). Tumor markers vary by component. Treatment planned according to the most aggressive component.
Distinct Features
The most heterogeneous appearance on ultrasonography is seen in this type. Cystic areas (teratoma), solid hypoechoic areas (embryonal carcinoma), calcifications (mature teratoma), and hemorrhagic foci may coexist. AFP and beta-HCG may be elevated together.
Criteria
When embryonal carcinoma comprises >50% of the mixed tumor. More aggressive biological behavior, higher metastasis risk. AFP normal or mildly elevated, beta-HCG may be elevated. High risk of lymphatic and hematogenous spread.
Distinct Features
On ultrasonography, predominantly solid hypoechoic component with fewer cystic areas. Marked diffusion restriction in solid areas on DWI. Higher risk of tunica albuginea invasion and vascular invasion.
Criteria
When teratoma comprises >50% of the mixed tumor. Frequently seen in residual tumor after chemotherapy (growing teratoma syndrome). AFP and beta-HCG may be normal. Chemoresistant, surgical resection required.
Distinct Features
On ultrasonography, predominant cystic component and calcifications. Fewer solid areas. Fat density (-20 to -100 HU) and calcifications on CT confirm teratoma component. Areas showing signal loss on fat-suppressed MRI sequences.
Criteria
When yolk sac tumor comprises >50% of the mixed tumor. Characteristic marked serum AFP elevation. Beta-HCG normal. Schiller-Duval bodies are pathognomonic histological finding.
Distinct Features
Solid-cystic mixed pattern on ultrasonography, cavernous-reticular pattern may be seen. Mixed signal on T2 MRI. Pure yolk sac tumor is the most common testicular tumor in childhood.
Distinguishing Feature
Seminoma shows homogeneous hypoechoic appearance on ultrasonography, while NSGCT has heterogeneous composition with cystic areas, calcifications, and necrosis foci. AFP is always normal in seminoma; AFP and/or beta-HCG elevation is expected in NSGCT.
Distinguishing Feature
Pure teratoma has predominantly cystic structure with calcifications and fat components but does not show prominent solid cellular areas. NSGCT also contains aggressive solid components like embryonal carcinoma. Tumor markers are usually normal in pure teratoma.
Distinguishing Feature
In burned-out GCT, the testicular lesion is typically seen as a small, calcified scar, and tumor markers may be elevated or may present with retroperitoneal mass. In NSGCT, the testicular mass is active and large.
Distinguishing Feature
Epidermoid cyst shows concentric ring ('onion ring') pattern and is completely avascular. NSGCT has irregular heterogeneous structure with prominent vascularity. Tumor markers are normal in epidermoid cyst.
Distinguishing Feature
Testicular abscess presents as a hypoechoic-heterogeneous collection with peripheral vascularity, clinically accompanied by fever and pain. NSGCT presents as a painless mass with internal vascularity. Elevated CRP and leukocytes are expected in abscess.
Urgency
highManagement
Radical inguinal orchiectomy followed by staging CT (chest/abdomen/pelvis). BEP chemotherapy (bleomycin, etoposide, cisplatin) is standard for advanced stages. Post-chemotherapy RPLND for residual masses. Unlike seminoma, radiation therapy is not effective.Biopsy
Not NeededFollow-up
Regular surveillance with CT, AFP, beta-HCG, LDH. More intensive follow-up than seminoma due to higher relapse risk. Stage I: surveillance with CT every 2-3 months for first year. Post-chemotherapy: CT assessment of residual masses, RPLND if needed.NSGCT exhibits more aggressive biological behavior than seminoma but is a treatable disease with high chemotherapy response rates. Radical inguinal orchiectomy is the standard first-line treatment. BEP chemotherapy is the gold standard in advanced stages. It is resistant to radiation therapy. Retroperitoneal lymph node dissection (RPLND) may be needed for post-chemotherapy residual masses — mature teratoma is chemoresistant and must be surgically resected. AFP normalization is critical in monitoring treatment response.
Non-seminomatous germ cell tumors follow a more aggressive course than seminoma and tend to metastasize hematogenously early (lung most common). Radical inguinal orchiectomy is the primary treatment approach. In stage I, surveillance or nerve-sparing retroperitoneal lymph node dissection (RPLND) is performed. In advanced stages, cisplatin-based chemotherapy (BEP regimen) achieves high cure rates. Tumor markers (AFP, beta-hCG, LDH) are critically important for monitoring treatment response.